304
Views
1
CrossRef citations to date
0
Altmetric
Articles/Brief Reports

Ultrasound Doppler enthesitis shows sensitivity to change after biological therapy in spondyloarthritis and psoriatic arthritis patients

, , , &
Pages 196-204 | Accepted 21 Apr 2021, Published online: 21 Jun 2021
 

Abstract

Objective

To explore the sensitivity to change in power Doppler (PD) enthesitis in active spondyloarthritis (SpA) and psoriatic arthritis (PsA) patients.

Method

This was a longitudinal study in patients with SpA and PsA with active disease [patients starting or switching to biological disease-modifying anti-rheumatic drugs (bDMARDs)]. The MAdrid Sonographic Enthesitis Index (MASEI) was performed at baseline and at 3 and 6 month visits. The MASEI and Outcome Measures in Rheumatology (OMERACT) PD enthesitis definitions were checked. Reliability analysis among three readers was performed with ultrasound (US)-recorded videos.

Results

US examinations of 25 patients were included; 16 (64%) had SpA and nine (36%) PsA. The median (interquartile range, IQR) age was 49 (41–61) years, and 13 patients (52%) were female. The median (IQR) 28-joint Disease Activity Score of 3.6 (2.3–4.2), Bath Ankylosing Spondylitis Disease Activity Index of 6.7 (6.1–7.4), and C-reactive protein value of 8.2 (1.6–20) reflected moderate to high disease activity at baseline. Both MASEI and OMERACT PD enthesitis improved significantly at 3 and 6 month follow-up (p < 0.05) and showed sensitivity to change (standard error of measurement = 0.47 and 0.61, respectively). Improvement in clinical activity outcomes was significantly associated with decreases in MASEI and OMERACT PD enthesitis counts (p < 0.05). The MASEI and OMERACT PD definitions had excellent reliability (kappa = 0.918 and 0.865, respectively).

Conclusion

PD enthesitis significantly improved at 3 and 6 month follow-up in patients undergoing bDMARD therapy. Both MASEI and OMERACT PD US enthesitis reflect response to treatment.

Acknowledgements

The authors acknowledge and thank the subjects who participated in this study for their contribution.

The authors received no specific funding for this work.

Author contributions

Study design was performed by JMC and EDM. Subject recruitment and US examination were performed by JMC. Reliability analysis was performed by JMC, CMV, and EDM. CPR collected the epidemiological and clinical data. JMC and EDM performed the statistical analysis. JMC, CMV, CPR, JAG, and EDM drafted the manuscript. All coauthors revised the final manuscript.

Disclosure statement

No potential conflict of interest was reported by the authors.

Ethics approval

The research protocol has been approved by the Research Ethical Committee of Hospital Universitatrio La Paz, and all patients gave informed written consent for their participation in the study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.